INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

25,799 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
37
RENAISSANCE TECHNOLOGIES LLC13F filer
TSLATesla, Inc.
ADD
BUY$378.40M
899.7K sh
Not disclosed
Page 224 of 645
← PrevNext →
Aug 13, 2026
quarterly
SEC 13F

Evidence

37
RENAISSANCE TECHNOLOGIES LLC13F filer
NFLXNETFLIX INC
ADD
BUY$484.48M
6.79M sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

37
RENAISSANCE TECHNOLOGIES LLC13F filer
METAMeta Platforms, Inc.
ADD
BUY$996.89M
1.77M sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

36
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$2.20M
13.2K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

36
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.36M
15.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
WK
Wanninger KurtEVP & Chief Operations Officer
MBCMasterBrand, Inc.
Open-market sale
SELL$461K
50.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9.28M
104.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
WD
Woolson DanielVP, GM-Infusion Capital
ICUIICU MEDICAL INC/DE
Open-market sale
SELL$982K
5,417 sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC Form 4

Evidence

36
MH
Morrone Louis H.EXECUTIVE VICE PRESIDENT
ABTABBOTT LABORATORIES
Open-market sale
SELL$643K
5,850 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
NA
Nanduru AnilSenior Vice President
GGenpact LTD
Open-market sale
SELL$586K
17.2K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

36
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$3.14M
19.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

35
EM
Eisenberg MosheChief Financial Officer
CAMTCAMTEK LTD
Open-market sale
SELL$111K
645 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

35
PJ
Polak Aldo J.Director
EVTCEVERTEC, Inc.
Open-market sale
SELL$30K
1,000 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
315 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

35
Derek TranDSelf
LTCLTC PROPERTIES INC
Sale
SELL$1,001 – $15KJul 28, 2025Aug 13, 2026
traded Jul 28, 2025
+381dHouse PTR

Evidence

35
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
455 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

34
TE
Taylor Timothy EvanDirector, VP, Finance & Operations
GSATGlobalstar, Inc.
Open-market sale
SELL$6.21M
75.0K sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC Form 4

Evidence

34
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$75K
3,402 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

34
SH
Shah HusnalChief Product Officer
FNKOFunko, Inc.
Open-market sale
SELL$52K
8,800 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

33
DB
Durso Jerome BenedictDirector, President and CEO
ALTAltimmune, Inc.
Open-market purchase
BUY$44K
15.0K sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.62M
62.4K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.52M
28.7K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
RENAISSANCE TECHNOLOGIES LLC13F filer
COPCONOCOPHILLIPS
NEW
BUY$210.26M
2.02M sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

32
RENAISSANCE TECHNOLOGIES LLC13F filer
SHELShell plc
NEW
BUY$209.01M
2.70M sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

32
RENAISSANCE TECHNOLOGIES LLC13F filer
RMROBINHOOD MKTS INC
TRIM
SELL$291.59M
2.91M sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

32
RENAISSANCE TECHNOLOGIES LLC13F filer
LINLINDE PLC
TRIM
SELL$324.19M
624.7K sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

32
YM
Young Kenneth MDirector, Chief Executive Officer
BWBabcock & Wilcox Enterprises, Inc.
Open-market purchase
BUY$68K
7,000 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
NA
Nanduru AnilSenior Vice President
GGenpact LTD
Open-market sale
SELL$402K
11.9K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
William R. KeatingDSelf
HWHCA INC. NOTE CALL MAKE WHOLE 5.62500% 09/01/2028
Purchase
BUY$15K – $50KJun 30, 2026Aug 13, 2026
traded Jun 30, 2026
+44dHouse PTR

Evidence

32
TA
Tezel AhmetChief Innovation Officer
LIVNLivaNova PLC
Open-market sale
SELL$208K
2,675 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
GL
Gruber David LDirector
LTCLTC PROPERTIES INC
Open-market purchase
BUY$134K
3,500 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

32
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.63M
9,934 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

32
RENAISSANCE TECHNOLOGIES LLC13F filer
UNHUNITEDHEALTH GROUP INC
TRIM
SELL$328.94M
791.4K sh
Not disclosedAug 13, 2026quarterlySEC 13F

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$22K
988 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,420
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$2,199
100 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$4,410
200 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$29K
1,332 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$2,211
100 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

31
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$6,252
300 sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence